Her2 Negative Breast Cancer Patients
1 clinical trials · Condition
◉ Watch Her2 Negative Breast Cancer Patients
| Record | Firm | Date |
|---|---|---|
| Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer (NCT01151046) | Merrimack Pharmaceuticals | 2010-06-01 |
Track Her2 Negative Breast Cancer Patients automatically
Every clearance here is in the API, with alerts when new ones post.